# A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects

> **NCT02134353** · PHASE3 · COMPLETED · sponsor: **Syntara** · enrollment: 423 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Inhaled mannitol
- **DRUG:** Placebo Comparator: Arm B - Control

## Key facts

- **NCT ID:** NCT02134353
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 423 (ACTUAL)
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02134353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02134353, "A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02134353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*